• Systemic Adverse Drug Reactions of Antihypertensive Agents

    Nov 1, 2016, 00:00

  • Measures of Clinical Benefit in Immuno-Oncology Studies

    Nov 1, 2016, 00:00

  • The European Social Preference Measurement (ESPM) Study- Conceptual Considerations and Implementation

    Nov 1, 2016, 00:00

  • Healthcare Expenditures and Equity in Healthcare Utilization for Lymphedema Patients in France

    Nov 1, 2016, 00:00

  • Time and Cost of Hospitalization for Salvage Therapy Among Adults with Philadelhphia (PH)-Negative B-Cell Relapsed/Refractory (R/R) Acute Lymphoblastic Leukaemia (ALL) In Spain

    Nov 1, 2016, 00:00

  • Assessment of Prescribing Indicators in Public and Private Primary Health Care Facilities in Indonesia

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Exercise for the Prevention of Cancer

    Nov 1, 2016, 00:00

  • Real World Evidence (RWE) to Enhance Value-Based Market Access of the PCSK9 Inihibitors in Italy- Treatment Patterns and Cv-Related Hospitalizations Among High Risk Hefh and Secondary Prevention Patients in Three Real-World Data Systems

    Nov 1, 2016, 00:00

  • Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain

    Nov 1, 2016, 00:00

  • Adherence, Healthcare Resource Utilization and Direct Medical Costs Among Patients with Alzheimer's Disease in Tianjin, China

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Threshold Proposal For Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Biosimilars And Reference Price Groups In Germany

    Nov 1, 2016, 00:00

  • The Humanistic and Economic Burden of Irritable Bowel Syndrome with Diarrhoea (IBS-D) by Disease Severity among Patients in The EU5 Region

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Market Access of Innovative Anticancer Drugs in Algeria- Funding Based on Clinical or Economic Evidence?

    Nov 1, 2016, 00:00

  • Secukinumab In The Management of Psoriatic Arthritis In Gree A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents- An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis Techniques

    Nov 1, 2016, 00:00

  • Simulating Patient-Level Profiles To Capture Patient Heterogeneity In Health-Economic Applications

    Nov 1, 2016, 00:00

  • Adherence of Patients with Type 2 Diabetes to Medications – The Role Of Risk Preferences

    Nov 1, 2016, 00:00

  • Potential Cost Savings of A Point-Of-Care Diagnostic Test Measuring Antipsychotic Plasma Levels for Treatment of Patients with Schizophrenia in Spain

    Nov 1, 2016, 00:00

  • High Prevalence But Poor Awareness And Knowledge of Atrial Fibrillation Among The Elderly In Hong Kong

    Nov 1, 2016, 00:00

  • Advanced Parkinson’s Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?

    Nov 1, 2016, 00:00

  • Cost of 1st Line Treatment Failure in Braf V600 Mutated Metastatic Melanoma in France

    Nov 1, 2016, 00:00

  • Budget And Patient Access Analysis To Second Line Therapy Of Multiple Sclerosis In Bulgaria

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Brca Mutation Testing for Early-Stage Breast Cancer Patients with Family History in Malaysia

    Nov 1, 2016, 00:00

  • The Association Between Loneliness and Healthcare Utilization Among Older Adults in Singapore

    Nov 1, 2016, 00:00

  • Considering or Not Adverse Events in Health Economic Models- A Pragmatic Approach

    Nov 1, 2016, 00:00

  • Impact of Animal Testing on Mental Health of Researchers

    Nov 1, 2016, 00:00

  • Utilities Associated with The Number of Days on Parenteral Support in The Treatment of Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • Survival and Resource use in The Treatment of Metastatic Renal Cell Carcinoma in Sweden- A Retrospective Analysis of Data from National Registries

    Nov 1, 2016, 00:00

  • Economic Evaluation of Dengue Vaccination in Bangkok Metropolitan Administration

    Nov 1, 2016, 00:00

  • Antiasthmatic Drug Prescribing Pattern Assessment at Medical Reimbursement in Employees Health Care Facility of Banaras Hindu University

    Nov 1, 2016, 00:00

  • The Effect of Acne on The Quality of Life In Bulgaria - Pilot Study

    Nov 1, 2016, 00:00

  • Adverse Events Associated with Intravenous Immunoglobulin in Thailand

    Nov 1, 2016, 00:00

  • Systematic Literature Review to Assess Prevalence of Gina-Defined Segments of Asthma and Phenotypes

    Nov 1, 2016, 00:00

  • How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

    Nov 1, 2016, 00:00

  • Access to New Health Technologies in The Brazilian Health System- Disseminating Information to Law Operators for Qualifying The Health Decisions

    Nov 1, 2016, 00:00

  • Comparison of Cost-Effectiveness Between Egfr-Tkis Therapy and Chemotherapy for Advanced Nsclc

    Nov 1, 2016, 00:00

  • The Coeliac Disease Assessment Questionnaire (Cdaq)- Development of a Patient-Reported Outcome Measure

    Nov 1, 2016, 00:00

  • Economic Burden of Rheumatoid Arthritis In Italy- Possible Consequences on Early Rapidly Progressing Patients

    Nov 1, 2016, 00:00

  • A Framework For Measuring Adherence To Multiple Medications

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis to Evaluate the Femtosecond Laser-Assisted Cataract Surgery in Children

    Nov 1, 2016, 00:00

  • Quick Assessment on Lung Cancer Screening with Low-Dose Computed Tomography

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine (CAM) Disclosure to the Health Care Providers- A Qualitative Insight from Malaysia Thalassemia Patients

    Nov 1, 2016, 00:00

  • Development Of Day Surgery In Hungary Between 2004-2014

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities Based on the Eq-5d in Studies of Lymphomas

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Depends on the Subsequent Treatment Sequen An Example from Multiple Sclerosis

    Nov 1, 2016, 00:00

  • PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?

    Nov 1, 2016, 00:00

  • Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey

    Nov 1, 2016, 00:00

  • Annual Cost and Effects of Switching to Insulin Degludec from Other Basal Insulins- Evidence from Swedish Real-World Data

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis is Associated with an Increased Risk of Depression in Elderly Patients in Germany

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective

    Nov 1, 2016, 00:00

  • Economic Analysis of Scaling Up Access to Modern Family Planning Methods in Low and Middle-Income Countries; Case Studies for Indonesia and Uganda

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment For Chronic Obstructive Pulmonary Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Identifying Higher-Value Subpopulations For Treatment In Heterogenous Rare Diseases- An Example Study of Early Responders to Teduglutide for Short Bowel Syndrome

    Nov 1, 2016, 00:00

  • A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Regorafenib In Gastrointestinal Stromal Tumours In England Using Crossover Adjustment Methods

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland

    Nov 1, 2016, 00:00

  • Diabetes Self-Management- Pharmacy Perspective

    Nov 1, 2016, 00:00

  • Patterns of Index Biologic Drug Registrations To A Pharmacovigilance Register of Psoriasis Patients

    Nov 1, 2016, 00:00

  • Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors Among Undergraduate Male Students In An Ethiopian University- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Type 2 Diabetes (T2DM) Treatment with Dapagliflozin as Add-On to Metformin in the Dominican Republic and Guatemala

    Nov 1, 2016, 00:00

  • HCV- Treat Ratio and Governance Footprints. Analysis of Regional Differences in Italy

    Nov 1, 2016, 00:00

  • Real World Evidence in Europe- A Snapshot of its Current Status

    Nov 1, 2016, 00:00

  • Business Intelligence for Detecting Possible Surgical Site Infections from Gallbladder Surgery (Chol) and Colon Surgery (Colo) in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • The Cost of Asthma In Italy

    Nov 1, 2016, 00:00

  • The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of On-Pump and Off-Pump Stable Multivessel Coronary Artery Bypass Grafting–mass iii 5-Year Follow-Up

    Nov 1, 2016, 00:00

  • Response to Targeted Therapy and Healthcare Resource Utilization (HRU)- A European Retrospective Chart Review Study in Patients With HER2+ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE

    Nov 1, 2016, 00:00

  • Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)

    Nov 1, 2016, 00:00

  • The Utilization of Health Services By The Older Europeans- An Econometric Analysis

    Nov 1, 2016, 00:00

  • Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study

    Nov 1, 2016, 00:00

  • Age and Gender Specific Trends in Acute Inpatient Stroke Incidence in Germany

    Nov 1, 2016, 00:00

  • Budgetary Impact Analysis of Reimbursement Varenicline in the Smoking Cessation Treatment of Patients with Major Depression in Spain

    Nov 1, 2016, 00:00

  • Can We Predict Adherence in Diabetes Patients Based on Medication Characteristics?

    Nov 1, 2016, 00:00

  • Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample

    Nov 1, 2016, 00:00

  • Variation of Data Source Used for Baseline Population and for Natural Course of Alzheimer's Disease Progression in Model-Based Economic Evaluation of Treatment of AD

    Nov 1, 2016, 00:00

  • Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions- The Importance of Comparator Strategies

    Nov 1, 2016, 00:00

  • The Declining Value of Economics in Canadian Cancer Reimbursement Reviews

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Western Europe

    Nov 1, 2016, 00:00

  • Economic Analyses of Flair® and Fluency® Plus Endovascular Stent Grafts for the Treatment of Vascular Access Stenosis- A U.S. Hospital and Payer Perspective

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Surgical Excision Vs Mohs Micrographic Surgery for Non-Melanoma Skin Cancer

    Nov 1, 2016, 00:00

  • Economic Evaluation of The Portuguese Needle Exchange Programme In Community Pharmacies (NEP-CP)

    Nov 1, 2016, 00:00

  • Assessment of Biosimilar Landscape in Korea, Malaysia, Singapore and Taiwan

    Nov 1, 2016, 00:00

  • An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • The Impact of Surgical Professional Education- A Review of Clinical and Economic Outcomes

    Nov 1, 2016, 00:00

  • Health Insurance Treatment Cost of Colorectal Cancer in Hungary

    Nov 1, 2016, 00:00

  • Treatment Patterns of ALK+ Non-Small Cell Lung Cancer in Japan

    Nov 1, 2016, 00:00

  • Costs, Outcomes And Uses Of New Drugs- Drug Assessment Reports Vs Real World Data

    Nov 1, 2016, 00:00

  • Heparin and Related Substances for Treating Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France

    Nov 1, 2016, 00:00

  • Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China

    Nov 1, 2016, 00:00

  • Direct Medical Resource Utilization For Reoperation After Intramedullary Fixation of Pertrochanteric HIP Fractures

    Nov 1, 2016, 00:00

  • Oab in Poland - This is Time for A Change

    Nov 1, 2016, 00:00

  • The Coordination Of Care In Pmaq-Ab- An Analysis Based On The Item Response Theory

    Nov 1, 2016, 00:00

  • Patient Individual Therapy as Appropriate Comparator in Amnog-Dossiers in The Field of Oncology- Status Quo and Strategic Implications For Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On- What Is The Path To Market Access So Far?

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Platinum Plus Paclitaxel Versus Platinum Plus Cyclophosphamide Among Patients with Early-Stage Ovarian Cancer in Taiwan

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure with Reduced Ejection Fraction- The Use of Model Calibration To Improve Generalisability To A UK CHF Population

    Nov 1, 2016, 00:00

  • Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

    Nov 1, 2016, 00:00

  • Nintedanib Plus Docetaxel as Second-Line Therapy in Patients with Non-Small-Cell Lung Cancer (NSCLC)- A Network Meta-Analysis vs. New Therapeutic Options

    Nov 1, 2016, 00:00

  • Directly Eliciting Personal Utility Functions From A Convenience Sample Of 30 Health Outcomes Professionals- A Pilot Study

    Nov 1, 2016, 00:00

  • Comparison of Medical Costs, Health Care Utilization, and Health Outcomes Between the Elderly with and Without Disabilities in Korea

    Nov 1, 2016, 00:00

  • Prescription Trend in Antihypertensive Drugs in Mumbai And Suburbs- A Survey

    Nov 1, 2016, 00:00

  • Use of A Claims Database To Document The Use and Effectiveness of Oral Vinorelbine (NVBO) in A Real World Setting France

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Health State Utility Values in Mulitple Myeloma

    Nov 1, 2016, 00:00

  • The Emerging Roles of Pharmacists in Selected Tertiary Hospitals in Pangasinan and La Union- Focus on Pharmaceutical Care and Pharmacovigilance

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The use of Rivaroxaban in Treatment of Venous Thromboembolism in Spain

    Nov 1, 2016, 00:00

  • The Impact of Rifaximin-A on Non-Elective Hospital Admission and Attendance Costs in Uk Patients with Hepatic Encephalopathy

    Nov 1, 2016, 00:00

  • Cardiovascular Safety of Saxagliptin In Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analysis

    Nov 1, 2016, 00:00

  • Challenges in the Assessment of Medical Devices- Recommendations from the Medtechta Project

    Nov 1, 2016, 00:00

  • Feasibility of Matching-Adjusted Indirect Comparison (MAIC) of Omalizumab (OMA) vs. Mepolizumab (Mepo) in Moderate-to-Severe Asthma

    Nov 1, 2016, 00:00

  • Work Productivity and use of Disease-Modifying Therapies in Multiple Sclerosis- Results From A Patient Survey Accessed Through Social Media

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Real Life Progression Free Survival and Treatment Patterns For Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapies in Fran Analysis of Ims Rwd Oncology Cross-Sectional Survey Data

    Nov 1, 2016, 00:00

  • Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries

    Nov 1, 2016, 00:00

  • Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In Mexico

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Cost of Healthcare Among Metastatic Lung Cancer Patients Receiving Chemotherapy

    Nov 1, 2016, 00:00

  • Mepolizumab For The Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials

    Nov 1, 2016, 00:00

  • The Economic Value of Olmesartan for The Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • Effects of Hbsag Positivity During Pregnancy on Adverse Maternal Outcomes- A Retrospective Database Analysis

    Nov 1, 2016, 00:00

  • Cost-Utility of Denosumab For The Treatment of Postmenopausal Osteoporosis In Colombia

    Nov 1, 2016, 00:00

  • Review of Insulin Listing in the National Drug Formulary of Malaysia

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients- A Network Meta-Analysis of Longitudinal Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

    Nov 1, 2016, 00:00

  • Health Care Applicability of A Patient-Centric Web Portal For Patients' Medication Experience

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Metastatic Gastroenteropancreatic Neuroendocrine Tumours In Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • Experiences And Attitudes Related To Screening of Patients Attended on A Colorectal Screening Pilot Program In Hungary

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population

    Nov 1, 2016, 00:00

  • The Burden of Selected Cancers in The United States- Health Behaviors and Healthcare Utilization of Survivors

    Nov 1, 2016, 00:00

  • Key Drivers of HTA Decisions for “Life-Changing” Drugs

    Nov 1, 2016, 00:00

  • Choice of First Opioid Prescription and the Transitions from Acute to Long Term Opioid Use – Findings from Big Data

    Nov 1, 2016, 00:00

  • Suggestion on Critical Illness Insurance in China

    Nov 1, 2016, 00:00

  • Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act?

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications and Relapse

    Nov 1, 2016, 00:00

  • Development of Antibiogram for Management of Aerobic Bacterial Infection in Diabetic Foot Ulcer

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Results in Significant Reductions in Annualized Relapse Rate (Arr) and Protective Effect on Disibiltiy Progression- Results From a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of The Disease Burden Associated with Hemophilia A In China

    Nov 1, 2016, 00:00

  • Drug Pricing And Reimbursement Processes In Algeria

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris

    Nov 1, 2016, 00:00

  • Invisible Lever for Access to Innovative Therapies in Bulgaria

    Nov 1, 2016, 00:00

  • International Reference Pricing Across EU

    Nov 1, 2016, 00:00

  • Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Granulocyte Colony-Stimulating Factor (G-Csf) as Adjunctive Therapy in Cancer Patients with Established Febrile Neutropenia

    Nov 1, 2016, 00:00

  • Global Evaluation of European Submission Template to Inform HTA and Payer Submissions

    Nov 1, 2016, 00:00

  • Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)

    Nov 1, 2016, 00:00

  • Effective Use of Long-Term Healthcare In Chile- Are International Migrants At Disadvantage of Universal Health Coverage

    Nov 1, 2016, 00:00

  • Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?

    Nov 1, 2016, 00:00

  • Use of Real World Data in Identifying Relevant Comparators in Medico Economic Models at EU5 Level- A Case Study on Multiple Myeloma

    Nov 1, 2016, 00:00

  • Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?

    Nov 1, 2016, 00:00

  • Influence of Perceived Risk on Willingness to Pay for Diagnosis of Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting

    Nov 1, 2016, 00:00

  • Central Nervous System, Multiple Sclerosis And Social Security- The Economic Burden On The Social Security System Pensions In Italy

    Nov 1, 2016, 00:00

  • The Impact On Societal Burden Of Changed Uptake Of Hormonal Treatments

    Nov 1, 2016, 00:00

  • Assessment Of Various Factors Influencing Quality Of Life In Pcos Patients Of Northern Telangana Region Of India

    Nov 1, 2016, 00:00

  • Gestational Diabetes Screening for Chinese Women- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Observational Study on Daily Life Practice in 15039 Patient with Multiple Sclerosis in France

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Status of Orphan Drugs and Reimbursement Recommendations and Decisions in Analysed European Countries

    Nov 1, 2016, 00:00

  • To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?

    Nov 1, 2016, 00:00

  • Self-Medication with Antibiotics in Sana'a City

    Nov 1, 2016, 00:00

  • Gout Diagnosis and Possible Increased Risk of Joint Replacement- A Population-Based Cohort Study of Older Adults

    Nov 1, 2016, 00:00

  • Job Burnout Predictors In Community Pharmacists In Serbia

    Nov 1, 2016, 00:00

  • Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment- A Series of Case Studies with Decision Makers Across European Countries

    Nov 1, 2016, 00:00

  • The Effect of Traditional Medicine on Quality of Life in Patients with Atopic Dermatitis- A Review of Recent Clinical Trials

    Nov 1, 2016, 00:00

  • Experience Seeking Appropriate Standards of Cost-Effectiveness Ratio- Updates and Challenges in Japanese Setting

    Nov 1, 2016, 00:00

  • Characteristics, Resources Utilization And Safety Profile of Patients with Acute Pain- A European Real World Evidence Study

    Nov 1, 2016, 00:00

  • Facing Challenges for a Cost Comparison of Day Surgical and Inpatient Varicose Vein Surgery

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

    Nov 1, 2016, 00:00

  • Biosimilars- Market Access and Market Penetration – A Comparison of France and Germany

    Nov 1, 2016, 00:00

  • A Pubmed Based Search on Cost Effectiveness and Health-Related Quality of Life Studies with Respect to Complementary and Alternative Medicines

    Nov 1, 2016, 00:00

  • Cholesterol Management in the US

    Nov 1, 2016, 00:00

  • Cost Analysis of Levofloxacin 750mg During 5 Days Vs Levofloxacin 500mg During 10 Days for the Treatment of Comunity-Acquired Pneumonia Under the Brazilian Public Hospital Perspective

    Nov 1, 2016, 00:00

  • The Burden of Depression in Japan

    Nov 1, 2016, 00:00

  • Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Cost And Resource Utilization Among Multiple Sclerosis Patients With Increasing Disability In Latin America

    Nov 1, 2016, 00:00

  • Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria

    Nov 1, 2016, 00:00

  • Use of Internet and Reliability of Information Obtained Online Concerning Medication Risks/Safety- Perceptions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • A Preliminary Cost-Utility Analysis of Non-Invasive Vagus Nerve Stimulation Therapy in Patients Suffering with Headache and Functional Disorder Multi-Morbidity

    Nov 1, 2016, 00:00

  • Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial

    Nov 1, 2016, 00:00

  • Impact of Inadequate Insulin Resuspension (IIR) on Clinical, Patient And Economic Outcomes- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Sleeping Pills Use Among Adults in Israel

    Nov 1, 2016, 00:00

  • Pharmacoutilization In Patients Suffering From Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

    Nov 1, 2016, 00:00

  • Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting

    Nov 1, 2016, 00:00

  • Impact and Importance of Real World Data in Asia- A Physician's Perspective

    Nov 1, 2016, 00:00

  • How Gifts and Brand Reminders Influence the Generic Brand Selection Among Physicians?

    Nov 1, 2016, 00:00

  • Burden of Diverticular Disease- An Observational Analysis Based on Italian Real World Data

    Nov 1, 2016, 00:00

  • Chemotherapy, Cytokines and Cancer-Related Fatigue- A Systematic Review of Quantitative Studies in 1312 Patients

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Secukinumab In The Management of Ankylosing Spondylitis In Greece

    Nov 1, 2016, 00:00

  • Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care

    Nov 1, 2016, 00:00

  • The Impact of Inflammatory Bowel Disease on Work Productivity- Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

    Nov 1, 2016, 00:00

  • Association Between Stages of Change and Medication Adherence Among Diabetic Patients in a Primary Health Care Setting in Qatar- A Preliminary Study

    Nov 1, 2016, 00:00

  • The Relationship Between Regret In Patient Decision-Making During The Clinical Process And Patient Factors—Tests Based On The Japanese Version Of The Decision Regret Scale(Drs)—

    Nov 1, 2016, 00:00

  • A Prospective Analysis of Adverse Drug Reaction in A Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • An Update of Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cells Transplant Patients

    Nov 1, 2016, 00:00

  • Kidney-Related Complications Are Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPD

    Nov 1, 2016, 00:00

  • Costs of Perennial Allergic Rhinitis And Asthma Increase with Level of Severity And Level of Disease Control

    Nov 1, 2016, 00:00

  • Utilization And Cost Of Antimicrobials Used In Medicine And Surgery Departments Of A Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Review of Multicriteria Decision Analysis Application for Decision-Making in Oncology

    Nov 1, 2016, 00:00

  • Exploring Determinants Of Polypharmacy In The Elderly Population In Austria

    Nov 1, 2016, 00:00

  • The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenan A Meta-Analysis

    Nov 1, 2016, 00:00

  • Launching Novel Antibiotics- Access Opportunities and Resistance in European Markets

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Latin-American (LATAM) Markets- Systematic Evaluation in 5 Latam Countries

    Nov 1, 2016, 00:00

  • A Clinical Literature Review of Coronary Artery Calcification and Current Treatment Outcomes in Japan

    Nov 1, 2016, 00:00

  • Substitutability of Dry Powder Inhalers- A Perspective from German Pulmonologists

    Nov 1, 2016, 00:00

  • Treatment Comparative Effectiveness In Rare Diseases- The Case of Transthyretin Familial Amyloid Polyneuropathy Survival

    Nov 1, 2016, 00:00

  • National Survey of Drug Information Centers Practice in Saudi Arabia- Evidence Based Medicine-Therapeutics Guidelines System (Ebm-Tg) At Moh

    Nov 1, 2016, 00:00

  • key Drivers for Market Penetration of Biosimilars in Europe

    Nov 1, 2016, 00:00

  • Patient Compliance to Treatment with Gliclazide for Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Humanistic and Economic Outcomes of Pharmacist-Provided Medication Reviews in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Access To New Drugs After The Introduction Of The 2011 Reimbursement Act In Poland

    Nov 1, 2016, 00:00

  • Criteria Driving Values Assessments in Multiple Sclerosis Medicines

    Nov 1, 2016, 00:00

  • Economic Burden of Varicella In Children In Poland, 2011–2015

    Nov 1, 2016, 00:00

  • Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Economic Burden Of Primary Immunodeficiency In National Institute Of Pediatrics In Mexico

    Nov 1, 2016, 00:00

  • Pharmacists Manpower Analysis In Years 2006-2014 At Minstery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)

    Nov 1, 2016, 00:00

  • Comparison of the Trends of Orphan Drugs Designations and Approvals in the United States and Europe In Oncology

    Nov 1, 2016, 00:00

  • Estimating the Economic Impact Due to Productivity Losses of Diabetes and Major Depressive Disorder in Singapore- Human Capital Versus Friction cost Approaches

    Nov 1, 2016, 00:00

  • A Parallel Observational and Prospective Study on Pharmacoeconomic Analysis and Prescribing Pattern of Antibiotics in Infectious Diseases

    Nov 1, 2016, 00:00

  • Comparative Analysis of Consumption of Antipsychotic Drugs For Treating Schizophrenia in Hospitals in Russian Federation

    Nov 1, 2016, 00:00

  • Compare Policies And Research Situation Of Rare Diseases And Orphan Drugs Between China And Other Countries

    Nov 1, 2016, 00:00

  • Increase Hospital Physicians’ Awareness of Expenditure Generated by Their Prescription in the Ambulatory Sector- Learning from the Experience of the 37 Public Hospitals of Paris in Diabetology

    Nov 1, 2016, 00:00

  • Real Life Data Demonstrate Significant Reductions In HBA1C In T2DM Patients Switching From Other Insulins To Insulin Degludec

    Nov 1, 2016, 00:00

  • The Effects Of Food Prices On Weight Outcomes. A Systematic Review Of The Moderating Effects Of Income And Initial BMI

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of HDM Slit-Tablet For Allergen Immunotherapy In House Dust Mite Induced Allergic Rhinitis with or Without Allergic Asthma In An Italian Setting

    Nov 1, 2016, 00:00

  • Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Different Biologic Agents For Ankylosing Spondylitis Treatment In Russia

    Nov 1, 2016, 00:00

  • The Effects of Pay for Response and Maximum Price CAP Schemes on Payer and Provider Risk

    Nov 1, 2016, 00:00

  • Preferences For The Characteristics Of Home Enteral Nutrition (Hen) Via Tube Feeding- A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Prescription Data in Australia- How Useful is this ‘Big' Data?

    Nov 1, 2016, 00:00

  • Innovation - A Value For Health And Growth, An International Study On Market Access Stakes For Therapeutic Innovation

    Nov 1, 2016, 00:00

  • Prevalence of Severe Asthma and Poorly Controlled Severe Asthma During 2009–2013 in The Netherlands

    Nov 1, 2016, 00:00

  • A Real-World Evaluation of the Clinical and Economic Burden of United States Veteran Patients with Post-Traumatic Stress Disorder

    Nov 1, 2016, 00:00

  • A Meta Regression Analysis of Utility Weights for Breast Cancer

    Nov 1, 2016, 00:00

  • The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis- A Case Study in Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Retrospective Review of Observational Data Requested by the French Health and Technology Assessment Agency- How are Results Taken Into Account?

    Nov 1, 2016, 00:00

  • Role of Clinical Pharmacist in Optimizing Reimbursement Originating from Performance-Based Risk-Sharing Arrangements- The Experience of the University Hospital “G. Martino” from Messina, Italy

    Nov 1, 2016, 00:00

  • Economic Analysis of Evarrest Sealant Matrix Compared with Standard of Care in Severe Soft Tissue Surgical Bleeding- A France Hospital Perspective

    Nov 1, 2016, 00:00

  • A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines

    Nov 1, 2016, 00:00

  • Hepatitis C – Real World Effectiveness of HCV Treatment in Poland

    Nov 1, 2016, 00:00

  • G-BA Early Advice VS. EMA/HTA Parallel Advice from a German Perspective

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban Versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Antihypertensive Drugs Usage by Combination of ACEI – CCB and ACEI – Diuretic in Outpatient Hypertension Therapy at Rsal Mintohardjo Jakarta (July-November 2015)

    Nov 1, 2016, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

    Nov 1, 2016, 00:00

  • Access To Innovative Medicines In The Czech Republic- Length Of Price And Reimbursement (PR) Procedures

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United Kingdom

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted By Absenteeism Associated with Sclerosis Multiplex In Poland

    Nov 1, 2016, 00:00

  • The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis Models

    Nov 1, 2016, 00:00

  • Knowledge and Perception of Medicine, Dentistry and Pharmacy Students of Malaysian University Regarding Ebola Virus Disease (EVD)

    Nov 1, 2016, 00:00

  • Understanding Methodological Differences Between and The Appropriate Application of Oncology Value Frameworks in Healthcare Decision-Making

    Nov 1, 2016, 00:00

  • Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm)- Patients Perspective In Ths Spanish Health Care System

    Nov 1, 2016, 00:00

  • Attribute Development Using Continuous Stakeholder Engagement to Prioritize Treatment Decisions- A Framework for Patient-Centered Research

    Sep 1, 2016, 00:00

  • Economic Impact of Integrated Care Models for Patients with Chronic Diseases- A Systematic Review

    Sep 1, 2016, 00:00

  • Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30

    Sep 1, 2016, 00:00

  • The Capability Approach- A Critical Review of Its Application in Health Economics

    Sep 1, 2016, 00:00

  • Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy

    Sep 1, 2016, 00:00

  • Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review

    Sep 1, 2016, 00:00

  • Decision Modeling for Cost-Utility Analysis

    Sep 1, 2016, 00:00

  • When Future Change Matters- Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices

    Sep 1, 2016, 00:00

  • A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective

    Sep 1, 2016, 00:00

  • A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies

    Sep 1, 2016, 00:00

  • Response to Editorial- Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • International Experiences in Quantitative Benefit-Risk Analysis to Support Regulatory Decisions

    Sep 1, 2016, 00:00

  • Estimating Health-State Utility for Economic Models in Clinical Studies- An ISPOR Good Research Practices Task Force Report

    Sep 1, 2016, 00:00

  • Impact of Treatment Subsidies and Cash Payouts on Treatment Choices at the End of Life

    Sep 1, 2016, 00:00

  • A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research- The Key Principles for Informing Coverage Decisions

    Sep 1, 2016, 00:00

  • Developing a Patient-Centered Benefit-Risk Survey- A Community-Engaged Process

    Sep 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection

    Sep 1, 2016, 00:00

  • Adherence to Self-Care Behaviors among Patients with Type 2 Diabetes—The Role of Risk Preferences

    Sep 1, 2016, 00:00

  • First and Foremost Battle the Virus- Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Table of Contents

    Sep 1, 2016, 00:00

  • Increasing Patient Involvement in Drug Development

    Sep 1, 2016, 00:00

  • Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction- A Discrete Choice Experiment

    Sep 1, 2016, 00:00

  • Copyright/Subscription

    Sep 1, 2016, 00:00

  • Instructions for Authors

    Sep 1, 2016, 00:00

  • Patient Preferences in Regulatory Benefit-Risk Assessments- A US Perspective

    Sep 1, 2016, 00:00

  • Financing a Cure for Diabetes in a Multipayer Environment

    Sep 1, 2016, 00:00

  • Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement

    Sep 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Sep 1, 2016, 00:00

  • Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions- The European Union Perspective

    Sep 1, 2016, 00:00

  • Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease- Are Current Models Suitable to Evaluate Personalized Medicine?

    Sep 1, 2016, 00:00

  • Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence- The Psychometric Performance of the ICECAP-A and the EQ-5D-5L

    Sep 1, 2016, 00:00

  • Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database

    Sep 1, 2016, 00:00

  • Clinical Guidelines- A NICE Way to Introduce Cost-Effectiveness Considerations?

    Jul 1, 2016, 00:00

  • Health or Happiness? A Note on Trading Off Health and Happiness in Rationing Decisions

    Jul 1, 2016, 00:00

  • Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model- A Simulation Study

    Jul 1, 2016, 00:00

  • Development of Seasonal Influenza Vaccination Recommendations- Relevance and Influence of the Evidence on the Decision-Making Process in France and The Netherlands

    Jul 1, 2016, 00:00

  • Breakthrough Cancer Pain- Ten Commandments

    Jul 1, 2016, 00:00

  • A Framework for Developing the Structure of Public Health Economic Models

    Jul 1, 2016, 00:00

  • Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C

    Jul 1, 2016, 00:00

  • Instructions for Authors

    Jul 1, 2016, 00:00

  • Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy

    Jul 1, 2016, 00:00

  • A PROMIS Measure of Neuropathic Pain Quality

    Jul 1, 2016, 00:00

  • Predicting the Burden of Revision Knee Arthroplasty- Simulation of a 20-Year Horizon

    Jul 1, 2016, 00:00

  • A Tale of Two Thresholds- A Framework for Prioritization within the Cancer Drugs Fund

    Jul 1, 2016, 00:00

  • Cost-Effectiveness and Clinical Practice Guidelines- Have We Reached a Tipping Point?—An Overview

    Jul 1, 2016, 00:00

  • On the Estimation of the Cost-Effectiveness Threshold- Why, What, How?

    Jul 1, 2016, 00:00

  • Cholinesterase Inhibitor Utilization- The Impact of Provincial Drug Policy on Discontinuation

    Jul 1, 2016, 00:00

  • Table of Contents

    Jul 1, 2016, 00:00

  • Copyright/Subscription

    Jul 1, 2016, 00:00

  • About the Reliability of the Critical Review to Investigate the Generalizability of Economic Evaluations Conducted in Italy

    Jul 1, 2016, 00:00

  • Challenges in Measuring Cost and Value in Oncology- Making It Personal

    Jul 1, 2016, 00:00

  • Health Technology Assessment for Molecular Diagnostics- Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group

    Jul 1, 2016, 00:00

  • Comparison of Value Set Based on DCE and/or TTO Data- Scoring for EQ-5D-5L Health States in Japan

    Jul 1, 2016, 00:00

  • Estimating the Medical Care Costs of Obesity in the United States- Systematic Review, Meta-Analysis, and Empirical Analysis

    Jul 1, 2016, 00:00

  • How Many Alternatives Can Be Ranked? A Comparison of the Paired Comparison and Ranking Methods

    Jul 1, 2016, 00:00

  • Evaluating the Importance of Heterogeneity of Treatment Effect- Variation in Patient Utilities Can Influence Choice of the “Optimal” Oral Anticoagulant for Atrial Fibrillation

    Jul 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Jul 1, 2016, 00:00

  • Association between Time Since Cancer Diagnosis and Health-Related Quality of Life- A Population-Level Analysis

    Jul 1, 2016, 00:00

  • Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

    Jul 1, 2016, 00:00

  • Considering Cost-Effectiveness in Cardiology Clinical Guidelines- Progress and Prospects

    Jul 1, 2016, 00:00

  • Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients

    Jun 1, 2016, 00:00

  • Using the Evaluative Linguistic Framework for Questionnaires to Assess Comprehensibility of Self-Report Health Questionnaires

    Jun 1, 2016, 00:00

  • Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L

    Jun 1, 2016, 00:00

  • Mapping the COPD Assessment Test onto EQ-5D

    Jun 1, 2016, 00:00

  • Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in Anticoagulation

    Jun 1, 2016, 00:00

  • Editorial on Statistical Methods for the Analysis of Discrete Choice Experiments

    Jun 1, 2016, 00:00

  • Health Utilities for Multiple Sclerosis

    Jun 1, 2016, 00:00

  • Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies

    Jun 1, 2016, 00:00

  • Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force

    Jun 1, 2016, 00:00

  • A Randomized Controlled Trial of Two Distinct Shared Decision-Making Aids for Hip and Knee Osteoarthritis in an Ethnically Diverse Patient Population

    Jun 1, 2016, 00:00

  • Copyright/Subscription

    Jun 1, 2016, 00:00

  • Assessing Asthma Symptoms in Adolescents and Adults- Qualitative Research Supporting Development of the Asthma Daily Symptom Diary

    Jun 1, 2016, 00:00

  • Response to Letter to the Editor by Dr. Garattini

    Jun 1, 2016, 00:00

  • Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy

    Jun 1, 2016, 00:00

  • Open Access Publication in Value in Health

    Jun 1, 2016, 00:00

  • Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation—A Danish Nationwide Registry Study

    Jun 1, 2016, 00:00

  • The Impact of Patient-Centered versus Didactic Education Programs in Chronic Patients by Severity- The Case of Type 2 Diabetes Mellitus

    Jun 1, 2016, 00:00

  • A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support

    Jun 1, 2016, 00:00

  • Instructions for Authors

    Jun 1, 2016, 00:00

  • The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence from the ICON7 Trial

    Jun 1, 2016, 00:00

  • A Multidimensional Analysis of Prostate Surgery Costs in the United States- Robotic-Assisted versus Retropubic Radical Prostatectomy

    Jun 1, 2016, 00:00

  • Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis

    Jun 1, 2016, 00:00

  • Table of Contents

    Jun 1, 2016, 00:00

  • Developing a Measure of Value in Health Care

    Jun 1, 2016, 00:00

  • Dutch Tariff for the Five-Level Version of EQ-5D

    Jun 1, 2016, 00:00

  • Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer- A Value of Information Analysis

    Jun 1, 2016, 00:00

  • An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders’ Risk Tolerance for Hip Replacement Surgery

    Jun 1, 2016, 00:00

  • Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales

    Jun 1, 2016, 00:00

  • Efficient Value of Information Calculation Using a Nonparametric Regression Approach- An Applied Perspective

    Jun 1, 2016, 00:00

  • FUNCTIONAL FORM OF THE RELATIONSHIP BETWEEN ADHERENCE TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST THERAPY AND MEDICAL HEALTH CARE COSTS AMONG PATIENTS WITH TYPE 2 DIABETES IN THE UNITED STATES

    May 1, 2016, 00:00

  • Systematic Review of Burden of Hyperkalemia due to Angiotensin Enzyme Converting Inhibitors

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF EMPAGLIFLOZIN/LINAGLIPTIN AS 2ND-LINE THERAPY FOR ADULTS WITH TYPE 2 DIABETES

    May 1, 2016, 00:00

  • Quality Of Care And Health Care Utilization Among Foster Children In Mississippi Medicaid

    May 1, 2016, 00:00

  • INCREMENTAL HEALTH CARE COST PRIOR TO AND POST FIRST DIAGNOSIS OF MYASTHENIA GRAVIS IN THE COMMERICALLY AGED INSURED SAMPLE

    May 1, 2016, 00:00

  • HEALTH ECONOMIC IMPACT OF THE ADOPTION OF SHERLOCK 3CG® TIP CONFIRMATION SYSTEM FOR PERIPHERALLY INSERTED CENTRAL CATHETER PLACEMENT- A US HOSPITAL SYSTEMS PERSPECTIVE

    May 1, 2016, 00:00

  • HEALTH INFORMATION SEEKING PRIORITIES USING GOOGLE- WHAT ARE HEALTH SEEKERS LOOKING FOR?

    May 1, 2016, 00:00

  • Does A Web-Based Decision Aid Help Parents in making a Decision to Vaccinate their Child against Hpv- Findings from Alberta

    May 1, 2016, 00:00

  • PHARMACOVIGILANCE TREND ANALYSIS OF MEDICATION ERRORS

    May 1, 2016, 00:00

  • Identifying and Managing Patients with Symptoms of Statin Intoleran Results from a Survey of Clinicians in the United States

    May 1, 2016, 00:00

  • ARE ORPHAN DRUGS TREATED THE SAME ACROSS EUROPE- AN HTA CASE STUDY

    May 1, 2016, 00:00

  • Effectiveness Outcomes In Patients With Advanced Nsclc Treated In Real-World Community Oncology Settings- Results From A Prospective Medical Record Registry Study

    May 1, 2016, 00:00

  • HEMODIALYSIS REVERSE OSMOSIS MACHINES DISINFECTION VERSUS NEW PURCHASE- COST-EFFECTIVENESS ANALYSIS

    May 1, 2016, 00:00

  • One-Size-May-Not-Fit-All- A Reconsideration of Existing Approaches for Estimating Utilities of Multi-Morbidity

    May 1, 2016, 00:00

  • ALL-CAUSE HEALTH CARE RESOURCE UTILIZATION IN INDIVIDUALS WITH SICKLE CELL DISEASE AND SICKLE CELL CRISIS

    May 1, 2016, 00:00

  • Review of Cardiovascular Quality-Of-Care Metrics across Different Organizations in the United States

    May 1, 2016, 00:00

  • THE REAL – PANLAR (PAN AMERICAN LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY) PROJECT FOR ESTABLISHING CENTERS OF EXCELLENCE IN RHEUMATOID ARTHRITIS THROUGHOUT LATIN AMERICA

    May 1, 2016, 00:00

  • Economic Evaluation of An Automated Retinal Image Analysis In Australian Aboriginal And Torres Strait Islander Populations For Detection of Diabetic Retinopathy

    May 1, 2016, 00:00

  • French Prospective Multi-Center Cohort on The Decision Impact Assessment

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF DE-ESCALATION FROM MICAFUNGIN VERSUS ESCALATION FROM FLUCONAZOLE FOR SYSTEMIC CANDIDA INFECTIONS IN CHINA

    May 1, 2016, 00:00

  • Resource Utilization Associated With Non-Cystic Fibrosis Bronchiectasis Patients Who Are Being Treated For Exacerbations

    May 1, 2016, 00:00

  • HOSPITALIZATIONS FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA- INPATIENT TREATMENT IS INTENSIVE AND COSTLY

    May 1, 2016, 00:00

  • Independent Factors Affecting Patient Compliance to Private Insurer-Funded Health Case Management in Canada

    May 1, 2016, 00:00

  • Patients Out-of-Pocket and Caregivers Economic Burden in Patients with Ovarian Cancer- Survey Pilot@

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF DENGUE VACCINATION IN BRAZIL

    May 1, 2016, 00:00

  • HEALTH UTILITIES IN INHIBITOR NEGATIVE PATIENTS WITH HEMOPHILIA A ON PROPHYLAXIS IN THREE NORDIC COUNTRIES

    May 1, 2016, 00:00

  • RISK FACTORS OF OCCUPATIONAL INJURIES AND RELATED DISABILITIES AMONG AUTO MECHANICS IN THE INFORMAL SECTOR OF KUMASI, GHANA

    May 1, 2016, 00:00

  • Creating an Inventory of Risk Factors for Predicting Stroke among Atrial Fibrillation Patients- A Systematic Review

    May 1, 2016, 00:00

  • Treatment Patterns with Topical Rosacea Treatment

    May 1, 2016, 00:00

  • TRENDS IN PROSTATE CANCER SCREENING BEFORE AND AFTER PUBLICATION OF US PREVENTIVE SERVICES TASK FORCE DRAFT GUIDELINES- AN ANALYSIS OF DATA FROM A LARGE US LABORATORY SERVICE PROVIDER

    May 1, 2016, 00:00

  • Health Technology Assessment- A Trailblazer in Better Patient Care

    May 1, 2016, 00:00

  • Antibiotics Use Pattern And Appropriateness Among Children In The Treatment Of Cough/Cold And Diarrhea

    May 1, 2016, 00:00

  • COMPARISON OF DATA TO DECISION MODELS FOR A DATA CONSORTIA

    May 1, 2016, 00:00

  • Adherence and Persistence to Oral Migraine Prophylaxis Medications in Patients with Chronic Migraine

    May 1, 2016, 00:00

  • Costs and Outcomes Comparison of Tissue and Blood Based Biopsies for the Purpose of Biomarker Testing

    May 1, 2016, 00:00

  • Budget Impact Analysis of Erlotib as the First-Line Therapy of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in Vietnam

    May 1, 2016, 00:00

  • USE OF STATINS AND THE RISK OF INCIDENT DIABETES- A RETROSPECTIVE COHORT STUDY

    May 1, 2016, 00:00

  • Utilization Patterns of Lipid-Lowering Medications In High Risk Diabetic Patients

    May 1, 2016, 00:00

  • VALUING INJECTION FREQUENCY- TYPE 2 DIABETES STUDY WILLINGNESS-TO-PAY STUDY

    May 1, 2016, 00:00

  • The Infection Rate And Risk Factors For Patients Experiencing An Infection Following Deep Brain Stimulation Implantation- Evidence From A Large Us Payer Database

    May 1, 2016, 00:00

  • MAGNITUDE AND COST OF A MEASLES OUTBREAK IN DENVER- AN AGENT-BASED TRANSMISSION MODEL

    May 1, 2016, 00:00

  • A Comparison Of Antidepressant Drugs Approved By The Us Food And Drug Adminstration And Health Canada (1959-2015)

    May 1, 2016, 00:00

  • Examining The Incidence And Prevalence Of Alcohol Dependence Among Us Veteran Patients

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Tiotropium Bromide For Patients With Severe Obstructive Pulmonary Disease In Mexico

    May 1, 2016, 00:00

  • Depression and Coronary Heart Disease Risk- An Overview of Systematic Reviews

    May 1, 2016, 00:00

  • Comparative Assessment of Cost Effectiveness of Operative Methods For Spinal Disc Herniation Treatment

    May 1, 2016, 00:00

  • Multi-Indication Pricing- Pros, Cons, And Its Applicability To The United Kingdom

    May 1, 2016, 00:00

  • Long-Term Cost Utility Analysis Of Ideglira Versus Basal-Bolus Insulin Intensification Therapies In Patients With Type 2 Diabetes Inadequately Controlled On Basal Insulin In Spain

    May 1, 2016, 00:00

  • Comparison Of Resource Utilization And Associated Costs Between Users And Non-Users Of Atypical Antipsychotics To Treat Off-Label Mental Health Conditions- 2009-2013 Medical Expenditure Panel Survey

    May 1, 2016, 00:00

  • Co-Occurring Chronic Conditions and the Economic Burden Among Community-Dwelling Stroke Survivors in the United States- A Propensity Score Matched Analysis

    May 1, 2016, 00:00

  • Oral Nutrition Supplements in Inpatient and Outpatient Settings- Patient Characteristics at Time of Initiation

    May 1, 2016, 00:00

  • PREVALENCE OF PRESCRIPTION OPIOID ABUSE AS DETERMINED BY ICD CODES- A SYSTEMATIC REVIEW

    May 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80 (current)
  • »